The National Hemophilia Foundation’s (NHF) Medical and Scientific Advisory Council (MASAC) has issued the latest revision to their most comprehensive treatment document, which is periodically updated to provide information on current bleeding disorder therapies available in the U.S. The new document, which is listed below, was approved by MASAC on April 19, 2018.
Visit the NHF website to access MASAC Document #253: MASAC Recommendations Concerning Products Licensed for the Treatment of Hemophilia and Other Bleeding Disorders.
View the complete listing of all current MASAC documents here. To request a hard copy of any current documents, please contact HANDI, NHF’s information resource center: handi@hemophilia.org (link sends e-mail) or 1.800.424.2634.
